← Companies|Cellarity
Ce

Cellarity

Cambridge MAFounded 2017100 employees
Private CapbiotechPrivateOncology
Platform: Single-cell
Market Cap
N/A
All Drugs
3
Clinical Trials
8
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (3 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
CEL-9671CEL-9671NDA/BLA2Gene EditingCGRPCDK2iPSP
TalarasimodCEL-9920Phase 1/22RadioligandAuroraACD3xCD20CTCLACC
CEL-1794CEL-1794Approved4VaccinePARPPI3KiOCDNMOSD
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (8)
2025-08-06
CEL-1794 Ph3 Readout
NMOSD
Past
2025-09-03
Talarasimod Fast Track
CTCL
Past
2025-11-19
Talarasimod Ph2 Data
ACC
Past
2026-01-26
CEL-9671 Ph3 Readout
PSP
Past
2027-09-20
CEL-9671 Ph3 Readout
PSP
Ph3 Readout
2028-03-25
Talarasimod Ph2 Data
FL
Ph2 Data
2028-06-05
CEL-1794 Ph3 Readout
OCD
Ph3 Readout
2030-12-09
CEL-1794 Ph3 Readout
NMOSD
Ph3 Readout